Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.25 USD | -0.24% | -29.03% | +79.40% |
May. 08 | Transcript : Y-mAbs Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 07 | Earnings Flash (YMAB) Y-MABS THERAPEUTICS Posts Q1 Revenue $19.9M, vs. Street Est of $22.2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+79.40% | 539M | |
+5.46% | 109B | |
+11.26% | 105B | |
-0.38% | 22.25B | |
-12.18% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.70% | 16.85B | |
+2.91% | 13.76B | |
+35.48% | 12.46B |
- Stock Market
- Equities
- YMAB Stock
- News Y-mAbs Therapeutics, Inc.
- Wedbush Upgrades Y-mAbs Therapeutics to Outperform From Neutral, Notes Danyelza Return to Growth Trajectory; Raises PT to $13 From $5